Federated Hermes
PRME icon

Federated Hermes’s Prime Medicine PRME Stock Holding History

Federated Hermes’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6
Closed -$18 – 2174
2024
Q4 		$18 Buy
6
+2
+50% +$7 ﹤0.01% 2061
2024
Q3 		$15 Buy
+4
New +$19 ﹤0.01% 2041
2024
Q2 		– Sell
-3,576
Closed -$25K – 2114
2024
Q1 		$25K Buy
+3,576
New +$27.1K ﹤0.01% 1701
2023
Q2 		– Sell
-45
Closed -$554 – 2204
2023
Q1 		$554 Buy
+45
New +$733 ﹤0.01% 2068

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Federated Hermes's PRME Position: Q1 2025 in Review

Federated Hermes sold out of Prime Medicine (PRME) in Q1 2025, closing a stake of 6 shares — an estimated $18 sold.

Federated Hermes first reported a position in PRME in Q1 2023 and held it in 4 quarters. The position peaked at $25K in Q1 2024. 125 funds tracked by Wall St. Rank hold PRME as of Q1 2025.

  • Federated Hermes reported no remaining Prime Medicine position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 6 Prime Medicine shares in Q1 2025, an estimated $18.
  • Federated Hermes first reported a position in Prime Medicine in Q1 2023 and held it in 4 quarters.
  • Federated Hermes's Prime Medicine position peaked at $25K in Q1 2024.
  • 125 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.